Search Result
| 1 |
Mechanistic insight into the cholinergic, muscarinic and
antagonistic effects of Khat (Catha edulis) on native
nicotinic acetylcholine receptors
Abstract |
 Fulltext
|
| 2 |
Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: A structural approach
Abstract |
Fulltext
|
| 3 |
Molecular docking, ADMET, molecular dynamic simulation, synthesis, and preliminary antiproliferative study of 1,2,4-thiadiazole derivatives as possible histone deacetylase inhibitors
Abstract |
Fulltext
|
| 4 |
Determination of allyl isothiocyanate from Hedyotis herbacea and its in silico screening for wound healing activity
Abstract |
Fulltext
|
| 5 |
ERRATUM: Determination of allyl isothiocyanate from Hedyotis herbacea and its in silico screening for wound healing activity
Abstract |
Fulltext
|
| 6 |
Cytotoxic and alpha amylase-inhibitory metabolites from Tagetes minuta: In vitro evaluation and docking studies
Abstract |
Fulltext
|
| 7 |
In silico studies-assisted design, synthesis, and discovery of biologically active isatin derivatives
Abstract |
Fulltext
|
| 8 |
Design, synthesis and biological activities of 5H-dibenzo[b,f]azepine-5-carboxamide derivatives; Targeted hippocampal trypsin inhibition as a novel approach to treat epileptogenesis
Abstract |
Fulltext
|
| 9 |
Effects of anti-cyclooxygenases (COX-1 and COX-2), structure activity relationship, molecular docking and in silico ADMET of some synthesized chalcones
Abstract |
Fulltext
|
| 10 |
Chemical constituents of Combretum dolichopetalum: Characterization, antitrypanosomal activities and molecular docking studies
Abstract |
Fulltext
|
| 11 |
In silico investigation of the mechanism of action of kojic acid effects via protein-protein interaction network
Abstract |
Fulltext
|
| 12 |
Investigation into the prophylactic and therapeutic activity of coenzyme Q10 against COVID-19
Abstract |
Fulltext
|
| 13 |
Prediction of novel natural inhibitors of avian coccidia (Eimeria tenella) through molecular docking
Abstract |
Fulltext
|
| 14 |
Molecular docking studies of natural compounds of naringin on enzymes involved in the urea cycle pathway in hyperammonemia
Abstract |
Fulltext
|
| 15 |
Molecular interaction of 4-amino-N’-(benzoyloxy)-N-(2,4-dimethylphenyl)-1,2,5-oxadiazole-3-carboximidamide with the methotrexate binding site of human DHFR, and its implication in rheumatoid arthritis
Abstract |
Fulltext
|
| 16 |
In silico screening of potentially bioactive-anti-functional dyspepsia constituents of Magnoliae officinalis Cortex based on molecular docking and network pharmacology
Abstract |
Fulltext
|
| 17 |
Anti-proliferative activity of leaves of Launaea capitata Asteraceae: Phytochemical, cytotoxicity and in silico studies
Abstract |
Fulltext
|
| 18 |
In-silico studies of HMG-Co A reductase inhibitors present in fruits of Withania coagulans Dunal (Solanaceae)
Abstract |
Fulltext
|
| 19 |
Isolation, characterization, pharmacological evaluation and in silico modeling of bioactive secondary metabolites from Ziziphus oxyphylla a member of Rhamnaceae family
Abstract |
Fulltext
|
| 20 |
Soluble curcumin prepared by solid dispersion using four different carriers: Phase solubility, molecular modelling and physicochemical characterization
Abstract |
Fulltext
|
| 21 |
In silico model and design of novel 5α-reductase inhibitors for treatment of benign prostatic hyperplasia
Abstract |
Fulltext
|
| 22 |
In silico screening of anti-inflammatory constituents with good drug-like properties from twigs of Cinnamomum cassia based on molecular docking and network pharmacology
Abstract |
Fulltext
|
| 23 |
Design of dual inhibitors of human TNF-α and IL-6 with potentials for the treatment of rheumatoid arthritis
Abstract |
Fulltext
|
| 24 |
Synthesis and cytotoxicity studies on new pyrazole-containing oxime ester derivatives
Abstract |
Fulltext
|
| 25 |
In silico and in vivo anti-inflammatory studies of curcuminoids, turmeric extract with zinc oxide, and eugenol
Abstract |
Fulltext
|
| 26 |
Inhibition of TNF-α and IL-1 by compounds from selected plants for rheumatoid arthritis therapy: In vivo and in silico studies
Abstract |
Fulltext
|
| 27 |
In silico elucidation of potential drug target sites of the Thumb Index Fold Protein, Wnt-8b
Abstract |
Fulltext
|
| 28 |
In silico studies on novel inhibitors of MERS-CoV: Structure-based pharmacophore modeling, database screening and molecular docking
Abstract |
Fulltext
|
| 29 |
In silico design of small molecules targeting cathepsin-k for the treatment of osteoarthritis
Abstract |
Fulltext
|
| 30 |
New N-allylthiourea derivatives: Synthesis, molecular docking and in vitro cytotoxicity studies
Abstract |
Fulltext
|
| 31 |
Inhibition of microRNA-383 promotes apoptosis of human colon cancer cells by upregulation of caspase-2 gene expression
Abstract |
Fulltext
|
| 32 |
Molecular docking studies on rocaglamide, a traditional Chinese medicine for periodontitis
Abstract |
Fulltext
|
| 33 |
Novel hydroquinone derivatives alleviate algesia, inflammation and pyrexia in the absence of gastric ulcerogenicity
Abstract |
Fulltext
|
| 34 |
Synthesis, biological evaluation and molecular docking studies of Mannich bases derived from 1, 3, 4-oxadiazole-2-thiones as potential urease inhibitors
Abstract |
Fulltext
|
| 35 |
Fatal France clinical trial and the lessons learned: Application of in silico approaches to investigate the disposition of B1A10-2474 and possible safety concerns
Abstract |
Fulltext
|
| 36 |
Antiviral evaluation of an Hsp90 inhibitor, gedunin, against dengue virus
Abstract |
Fulltext
|
| 37 |
A system-level mechanistic investigation of traditional Chinese medicine, Yinlai Decoction, for related diseases
Abstract |
Fulltext
|
| 38 |
Molecular docking and in silico ADMET studies of silibinin and glycyrrhetic acid anti-inflammatory activity
Abstract |
Fulltext
|
| 39 |
Production of a phage-displayed single chain variable fragment antibody against infectious bursal disease virus
Abstract |
Fulltext
|
| 40 |
Simvastatin-nicotinamide co-crystal: design, preparation and preliminary characterization
Abstract |
Fulltext
|
| 41 |
In-silico investigations into natural products as non-nucleoside DNA methyltransferase 1 inhibitors for treating epi-mutation in gastric cancer
Abstract |
Fulltext
|
| 42 |
Protein expression of Myt272-3 recombinant clone and in silico prediction of a possible vaccine candidate against Mycobacterium tuberculosis
Abstract |
Fulltext
|
| 43 |
A holistic in silico approach to develop novel inhibitors targeting ErbB1 and ErbB2 kinases
Abstract |
Fulltext
|
| 44 |
In vivo and in silico investigation of selected herbal compounds as anti-tubercular agents
Abstract |
Fulltext
|
| 45 |
In silico assessment of drug-like properties of alkaloids from Areca catechu L nut
Abstract |
Fulltext
|
| 46 |
Design and Development of Halogenated Chalcone Derivatives as Potential Anticancer Agents
Abstract |
Fulltext
|
| 47 |
A Novel Mechanistic Approach to Identify New Antifungal Lead Compounds Based on Amphotericin B Molecular Architecture
Abstract |
Fulltext
|
| 48 |
Synthesis, Anticonvulsant Activity and In silco Studies of Schiff Bases of 2-Aminothiophenes via Guanidine-Catalyzed Gewald Reaction
Abstract |
Fulltext
|
| 49 |
Multivariate Modeling of Cytochrome P450 Enzymes for 4-Aminoquinoline Antimalarial Analogues using Genetic-Algorithms Multiple Linear Regression
Abstract |
Fulltext
|
| 50 |
Idala: An unnamed Function Peptide Vaccine for Tuberculosis
Abstract |
Fulltext
|
| 51 |
Computer-Aided Formulation - Myth or Reality
Abstract |
Fulltext
|
51 matching items found
|
Archives
| 2025; 24: |
1,
2,
3.
|
| 2024; 23: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2023; 22: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2022; 21: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2021; 20: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2020; 19: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2019; 18: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2018; 17: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2017; 16: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2016; 15: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2015; 14: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2014; 13: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2013; 12: |
1,
2,
3,
4,
5,
6.
|
| 2012; 11: |
1,
2,
3,
4,
5,
6.
|
| 2011; 10: |
1,
2,
3,
4,
5,
6.
|
| 2010; 9: |
1,
2,
3,
4,
5,
6.
|
| 2009; 8: |
1,
2,
3,
4,
5,
6.
|
| 2008; 7: |
1,
2,
3,
4.
|
| 2007; 6: |
1,
2,
3,
4.
|
| 2006; 5: |
1,
2.
|
| 2005; 4: |
1,
2.
|
| 2004; 3: |
1.
|
| 2003; 2: |
1,
2.
|
| 2002; 1: |
1,
2.
|
|
